Quantum optimization, AI and conventional analytics will be applied under a collaboration announced by INmune Bio and Quantum Computing Inc.,…
Arrowhead reported interim Phase 1/2a data showing its injectable RNA therapy crossed the blood-brain barrier and cut cerebrospinal tau by…
Cancer pathology software from Lunit, a Korean medical AI company, is headed into pharmaceutical research. A partnership with Discovery Life…
Google's AMIE diagnostic chatbot was put in front of real urgent-care patients, and a new Lancet study suggests it can…
A new ARPA-H program aims to simulate trials in silico and cut the number of patients needed.
Generate Biomedicines and Roswell Park have dosed the first patient with GB-5267, an armored CAR T built with AI to…
Absci's STORYLINE trial would test a generative-AI-designed antibody in about 150 endometriosis patients starting mid-2027.
Massive Bio has appointed a Seoul-based partner to grow its AI clinical trial matching business in Korea, where it has…